SEC 13F Intelligence

Vida Ventures Advisors, LLC / ALLO

Vida Ventures Advisors, LLC’s Allogene Therapeutics Inc Position

Does Vida Ventures Advisors, LLC own Allogene Therapeutics Inc (ALLO)? Yes — 1.80M shares worth $2M (+7.59% of its 13F portfolio) as of Q3 2025.

Position Value
$2M
Q3 2025
Shares
1.80M
% of Portfolio
+7.59%
Quarters Held
21
currently held

Position History ALLO

Reported value by quarter
Q3 ’20: $68MQ3 ’20Q4 ’20: $45MQ1 ’21: $63MQ2 ’21: $47MQ2 ’21Q3 ’21: $46MQ4 ’21: $27MQ1 ’22: $16MQ1 ’22Q2 ’22: $20MQ3 ’22: $19MQ4 ’22: $11MQ4 ’22Q1 ’23: $9MQ2 ’23: $9MQ3 ’23: $6MQ3 ’23Q4 ’23: $6MQ1 ’24: $8MQ2 ’24: $4MQ2 ’24Q3 ’24: $5MQ4 ’24: $4MQ1 ’25: $3MQ1 ’25Q2 ’25: $2MQ3 ’25: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20251.80M$2M+7.59%
Q2 20251.80M$2M+12.76%
Q1 20251.80M$3M+19.25%
Q4 20241.80M$4M+2.62%
Q3 20241.80M$5M+3.63%
Q2 20241.80M$4M+4.58%
Q1 20241.80M$8M+4.47%
Q4 20231.80M$6M+6.87%
Q3 20231.80M$6M+8.82%
Q2 20231.80M$9M+11.67%
Q1 20231.80M$9M+12.15%
Q4 20221.80M$11M+15.20%
Q3 20221.80M$19M+17.43%
Q2 20221.80M$20M+17.32%
Q1 20221.80M$16M+9.53%
Q4 20211.80M$27M+10.04%
Q3 20211.80M$46M+13.24%
Q2 20211.80M$47M+11.76%
Q1 20211.80M$63M+16.04%
Q4 20201.80M$45M+9.32%
Q3 20201.80M$68M+42.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vida Ventures Advisors, LLC’s full portfolio or all institutional holders of ALLO.